New devices, advancements in technology and unique MIGS approaches provide an expansive landscape for surgeons to manage IOP without invasive incisional surgeries or increasing medication burdens.
Since the approval of the iStent (Glaukos) in 2012, new devices and improved surgical techniques have continually advanced glaucoma treatment in the MIGS field. The ability to control glaucoma without intrusive surgery or additional medication has been a boon, according to Carlos Buznego, MD, an OSN Technology Board Member.
“Finding surgical procedures and techniques that have low complication
Uncategorized